Ann Pediatr Endocrinol Metab.  2021 Jun;26(2):72-73. 10.6065/apem.2121006edi02.

Islet cell transplantation transitioning to proven therapy for type 1 diabetes

• Kim SY

• KMID: 2517582
• DOI: http://doi.org/10.6065/apem.2121006edi02

Reference

References

1. Kochar IS, Jain R. Islet cell transplantation transitioning to proven therapy for type 1 diabetes. Ann Pediatr Endocrinol Metab. 2021; 26:86–91.

2. Shapiro AM, Lakey JR, Ryan EA. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000; 343:230–5.

3. Ryan EA, Paty BW, Senior PA. Five-year follow-up after clinical islet transplantation. Diabetes. 2000; 54:2060–9.

4. Bruni A, Gala-Lopez B, Pepper AR, Abualhassan NS, Shapiro AJ. Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges. Diabetes Metab Syndr Obes. 2014; 7:211–23.

5. Jung HS, Ahn YR, Oh SH. Enhancement of beta-cell regeneration by islet transplantation after partial pancreatectomy in mice. Transplantation. 2009; 88:354–9.

6. Lablanche S, Borot S, Wojtuscizyn A. Five-year metabolic, functional, and safety results of patients with type 1 diabetes: a prospective 13-year follow-up. Diabetes Care. 2015; 38:752–9.